World Journal of Clinical Pediatrics,
Год журнала:
2023,
Номер
12(3), С. 133 - 150
Опубликована: Июнь 7, 2023
Smell
disorders
are
the
most
frequent
persistent
coronavirus
disease
2019
(COVID-19)
complications.To
describe
patterns
and
characteristics
of
smell
taste
in
Egyptian
patients.Assessment
was
done
to
185
patients
(adults
=
150,
age:
31.41
±
8.63
years;
children
35;
15.66
1.63
years).
Otolaryngology
neuropsychiatric
evaluations
were
done.
Measurements
included:
A
clinical
questionnaire
(for
taste);
sniffin'
odor,
flavor
identification
tests
Questionnaire
Olfactory
Disorders-Negative
Statements
(sQOD-NS).Duration
11.53
3.97
ms
(6-24
ms).
Parosmia
(n
119;
64.32%)
developed
months
after
anosmia
(3.05
1.87
Objective
testing
showed
all,
ageusia
loss
20%
37)
nasal
oral
trigeminal
sensations
18%
33)
37),
respectively.
Patients
had
low
scoring
sQOD-NS
(11.41
3.66).
There
no
specific
differences
other
demographics
variables
which
could
distinguish
post-COVID-19
from
adults.The
course
small
supportive
neuronal
compromises.
Post-COVID-19
less
compared
disorders.
solely
dependent
on
not
demographics,
at
onset
or
profile
these
adults.
Life,
Год журнала:
2022,
Номер
12(10), С. 1556 - 1556
Опубликована: Окт. 7, 2022
Persistent
chemosensory
dysfunction
(PCD)
is
a
common
symptom
of
long-COVID.
Chemosensory
(CD)
as
well
SARS-CoV-2-specific
antibody
levels
and
CD8+
T-cell
immunity
were
investigated
in
cohort
44
healthcare
workers
up
to
median
721
days
after
positive
PCR
test.
CD
was
assessed
using
questionnaires
psychophysical
screening
tests.
After
days,
11
(25%)
participants
reported
PCD,
with
five
describing
an
impaired
quality
life.
One
participant
hyperosmia
(increased
sense
smell).
The
risk
PCD
at
higher
for
reporting
qualitative
changes
(parosmia
(altered
smell),
dysgeusia
taste),
or
phantosmia
(hallucination
smell))
during
initial
infection
than
those
isolated
quantitative
losses
the
first
COVID-19
(62.5%
vs.
7.1%).
main
recovery
rate
occurred
within
100
did
not
continue
until
follow-up
2
years.
No
correlation
found
between
CD,
but
we
observed
trend
percentage
responders
CD.
In
conclusion,
significant
proportion
patients
suffer
from
life
years
infection.
Qualitative
smell
taste
pose
PCD.
A
large
number
of
patients
with
olfactory
impairment
are
affected
by
parosmia
or
phantosmia.
This
study
aimed
to
examine
the
demographic
and
clinical
characteristics
parosmia.
The Journal of Laryngology & Otology,
Год журнала:
2023,
Номер
137(12), С. 1395 - 1400
Опубликована: Май 17, 2023
This
study
aimed
to
evaluate
the
recovery
of
olfactory
function
at
six
months
in
individuals
infected
with
coronavirus
disease
2019
omicron
variant,
using
psychophysical
tests.A
prospective
case-control
that
included
severe
acute
respiratory
syndrome
coronavirus-2
patients
February
and
March
2022
was
conducted.
Patients
underwent
Sniffin'
Sticks
test
within
10
days
infection
again
after
least
6
months.
The
scores
were
compared
those
a
control
group.In
all,
102
120
controls
enrolled
study.
At
baseline,
26
(25.5
per
cent)
self-reported
smell
loss.
median
threshold,
discrimination
identification
score
33.6
(interquartile
range,
12.5)
for
cases
36.5
4.38)
(p
<
0.001).
Based
on
scores,
12
34
reported
dysfunction
Eighty
re-evaluation
months;
37.1
4.75)
no
significant
differences
controls.Six
infection,
prevalence
did
not
differ
significantly
from
population.
World Journal of Clinical Pediatrics,
Год журнала:
2023,
Номер
12(3), С. 133 - 150
Опубликована: Июнь 7, 2023
Smell
disorders
are
the
most
frequent
persistent
coronavirus
disease
2019
(COVID-19)
complications.To
describe
patterns
and
characteristics
of
smell
taste
in
Egyptian
patients.Assessment
was
done
to
185
patients
(adults
=
150,
age:
31.41
±
8.63
years;
children
35;
15.66
1.63
years).
Otolaryngology
neuropsychiatric
evaluations
were
done.
Measurements
included:
A
clinical
questionnaire
(for
taste);
sniffin'
odor,
flavor
identification
tests
Questionnaire
Olfactory
Disorders-Negative
Statements
(sQOD-NS).Duration
11.53
3.97
ms
(6-24
ms).
Parosmia
(n
119;
64.32%)
developed
months
after
anosmia
(3.05
1.87
Objective
testing
showed
all,
ageusia
loss
20%
37)
nasal
oral
trigeminal
sensations
18%
33)
37),
respectively.
Patients
had
low
scoring
sQOD-NS
(11.41
3.66).
There
no
specific
differences
other
demographics
variables
which
could
distinguish
post-COVID-19
from
adults.The
course
small
supportive
neuronal
compromises.
Post-COVID-19
less
compared
disorders.
solely
dependent
on
not
demographics,
at
onset
or
profile
these
adults.
